Keywords: codexis, produce, mystery, generic, teva, privately-held, biotechnology

Codexis to produce "mystery generic" for Teva

Article | 12 January 2009

Codexis, a privately-held US biotechnology firm, has entered into a licensing agreement with Israel's Teva Pharmaceutical Industries to produce one ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Teva Pharmaceutical Industries

Go to company listing